Article Abstract

Can we omit radiotherapy in case of brain metastases for patients with mutant EGFR lung adenocarcinoma?

Authors: Paul Jules Van Houtte, Daniel Devriendt


The paper presented by Magnuson et al. is a multiinstitutional retrospective study looking to the treatment of brain metastases among patients with tyrosine kinase inhibitor naive epidermal growth factor mutant non-small cell lung cancer: they concluded that deferral of radiotherapy is associated with inferior survival and the best approach is radiosurgery (RS) followed by EGFR-TKI to avoid the neurocognitive toxicity of whole brain radiotherapy (WBRT) (1).